- Home
- ATHA vs JFU Comparison
ATHA vs JFU Comparison
Compare ATHA & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- JFU
- Stock Information
- Founded
- ATHA 2011
- JFU 2006
- Country
- ATHA United States
- JFU China
- Employees
- ATHA N/A
- JFU N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- JFU Finance: Consumer Services
- Sector
- ATHA Health Care
- JFU Finance
- Exchange
- ATHA Nasdaq
- JFU Nasdaq
- Market Cap
- ATHA 14.8M
- JFU 17.1M
- IPO Year
- ATHA 2020
- JFU 2019
- Fundamental
- Price
- ATHA $0.36
- JFU $2.57
- Analyst Decision
- ATHA Hold
- JFU
- Analyst Count
- ATHA 3
- JFU 0
- Target Price
- ATHA $0.50
- JFU N/A
- AVG Volume (30 Days)
- ATHA 149.8K
- JFU 22.0K
- Earning Date
- ATHA 11-06-2025
- JFU 01-01-0001
- Dividend Yield
- ATHA N/A
- JFU N/A
- EPS Growth
- ATHA N/A
- JFU N/A
- EPS
- ATHA N/A
- JFU 0.58
- Revenue
- ATHA N/A
- JFU $42,467,427.00
- Revenue This Year
- ATHA N/A
- JFU N/A
- Revenue Next Year
- ATHA N/A
- JFU N/A
- P/E Ratio
- ATHA N/A
- JFU $4.52
- Revenue Growth
- ATHA N/A
- JFU N/A
- 52 Week Low
- ATHA $0.22
- JFU $1.01
- 52 Week High
- ATHA $0.83
- JFU $3.60
- Technical
- Relative Strength Index (RSI)
- ATHA 36.59
- JFU 68.51
- Support Level
- ATHA $0.35
- JFU $2.41
- Resistance Level
- ATHA $0.40
- JFU $2.75
- Average True Range (ATR)
- ATHA 0.02
- JFU 0.26
- MACD
- ATHA -0.00
- JFU -0.00
- Stochastic Oscillator
- ATHA 11.86
- JFU 35.24
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.